Eli Lilly to help train doctors on drug-resistant TB
GENEVA (Reuters) - U.S. pharmaceutical company Eli Lilly will donate $1 million to train doctors treating tuberculosis (TB), a disease that infects 9 million people every year and kills nearly 2 million.
<p><img src="http://feeds.reuters.com/~a/reuters/scienceNews?i=7FoP15" border="0"></img> (http://feeds.reuters.com/~a/reuters/scienceNews?a=7FoP15)</p><div class="feedflare">
<img src="http://feeds.reuters.com/~f/reuters/scienceNews?i=PVEZcH" border="0"></img> (http://feeds.reuters.com/~f/reuters/scienceNews?a=PVEZcH) <img src="http://feeds.reuters.com/~f/reuters/scienceNews?i=Ot1qkh" border="0"></img> (http://feeds.reuters.com/~f/reuters/scienceNews?a=Ot1qkh) <img src="http://feeds.reuters.com/~f/reuters/scienceNews?i=EkPUJh" border="0"></img> (http://feeds.reuters.com/~f/reuters/scienceNews?a=EkPUJh)
</div><img src="http://feeds.reuters.com/~r/reuters/scienceNews/~4/289344625" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/scienceNews/~3/289344625/idUSL1346000120080513